文献速递肾癌与肾肿瘤

深度学习在CT上自动鉴别良性肾嗜酸细胞瘤与嫌色细胞癌

Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning.
PubMed 文献 · BJU Int · 2020-02-06

本研究开发并评估了一种基于人工智能和图像处理的半自动方法,利用卷积神经网络在CT图像上测量肿瘤与皮质早期峰值强化比(PEER),以鉴别CD117阳性嗜酸细胞瘤与嫌色细胞型肾细胞癌(ChRCC)。CNN在192例患者图像上训练验证识别肾+肿瘤区域,对剩余20例患者自动测量PEER分类肿瘤类型,与病理相比准确率95%(敏感性100%,特异性89%),PEER比值的均方根误差为0.15。

要点

  • CNN识别肾+肿瘤区域的平均Dice相似度评分为0.66±0.14。
  • PEER自动评估分类肿瘤类型准确率95%,敏感性100%,特异性89%。
  • 深度学习可辅助无创鉴别CD117阳性良性嗜酸细胞瘤与恶性ChRCC。

核心结论

  • 深度学习通过计算机视觉获得的PEER测量可可靠鉴别CD117阳性良性嗜酸细胞瘤与恶性ChRCC。

研究设计与样本

  • CNN在192例患者图像上训练和验证以识别肾+肿瘤区域。
  • 对剩余20例CD117阳性嗜酸细胞瘤或ChRCC患者,手动分割肿瘤后自动测量PEER进行肿瘤类型鉴别。

主要发现

  • CNN识别肾+肿瘤区域的平均±标准差Dice相似度评分为0.66±0.14。
  • PEER评估肿瘤类型分类准确率95%(敏感性100%,特异性89%),与最终病理结果比较,PEER比值的均方根误差为0.15。

临床怎么用

  • 该AI辅助方法有望用于CT图像上无创鉴别CD117阳性良性嗜酸细胞瘤与恶性ChRCC,辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop and evaluate the feasibility of an objective method using artificial intelligence (AI) and image processing in a semi-automated fashion for tumour-to-cortex peak early-phase enhancement ratio (PEER) in order to differentiate CD117(+) oncocytoma from the chromophobe subtype of renal cell carcinoma (ChRCC) using convolutional neural networks (CNNs) on computed tomography imaging. METHODS: The CNN was trained and validated to identify the kidney + tumour areas in images from 192 patients. The tumour type was differentiated through automated measurement of PEER after manual segmentation of tumours. The performance of this diagnostic model was compared with that of manual expert identification and tumour pathology with regard to accuracy, sensitivity and specificity, along with the root-mean-square error (RMSE), for the remaining 20 patients with CD117(+) oncocytoma or ChRCC. RESULTS: The mean ± sd Dice similarity score for segmentation was 0.66 ± 0.14 for the CNN model to identify the kidney + tumour areas. PEER evaluation achieved accuracy of 95% in tumour type classification (100% sensitivity and 89% specificity) compared with the final pathology results (RMSE of 0.15 for PEER ratio). CONCLUSIONS: We have shown that deep learning could help to produce reliable discrimination of CD117(+) benign oncocytoma and malignant ChRCC through PEER measurements obtained by computer vision.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Baghdadi A, Aldhaam NA, Elsayed AS, et al. Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning. BJU Int. 2020. PMID: 31901213. doi:10.1111/bju.14985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。